Please login to the form below

Not currently logged in
Email:
Password:

sembragiline

This page shows the latest sembragiline news and features for those working in and with pharma, biotech and healthcare.

EMA unveils draft guidelines for Alzheimer’s disease research

EMA unveils draft guidelines for Alzheimer’s disease research

Last year Roche and Evotec's sembragiline failed a phase II trial and Pfizer this week announced it has halted development of its candidate, PF-05212377, after it too failed to

Latest news

  • Roche and Evotec’s Alzheimer’s drug ineffective Roche and Evotec’s Alzheimer’s drug ineffective

    Sembragiline failed to show cognitive and memory benefits. The quest for an effective therapy for Alzheimer's disease seems to have claimed another casualty, with a drug developed by Evotec and ... Roche reports that sembragiline – a drug in the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics